Metabolites(nmol/L) | Proportions of patients experiencing severe asthma exacerbation | Proportions of patients experiencing severe asthma exacerbation | Severe exacerbation times | Severe exacerbation times |
OR(95%CI) | P value | OR(95%CI) | P value | |
Adenine | 0.997(0.994, 1.001) | 0.146 | 0.998(0.995, 1.001) | 0.123 |
Phosphorylcholine | 1.030(0.986, 1.076) | 0.181 | 1.000(1.000,1.000) | 0.090 |
Adenosine 5’-monophosphate | 1.000(1.000, 1.000) | 0.050 | 1.000(1.000,1.000) | 0.008 |
Pyruvate | 1.000(1.000, 1.000) | 0.350 | 1.000(1.000,1.000) | 0.179 |
3-Hydroxyisovaleric acid | 0.996(0.992, 1.001) | 0.108 | 0.996(0.992, 1.000) | 0.053 |
Allantoin | 1.000(1.000, 1.000) | 0.136 | 1.000(1.000, 1.000) | 0.043 |
N-Acetylneuraminic acid | 1.000(1.000, 1.000) | 0.125 | 1.000(1.000, 1.000) | 0.124 |
Nicotinamide | 1.001(0.999,1.003) | 0.248 | 1.001(1.000, 1.002) | 0.021 |
Tyramine | 1.015(0.955, 1.080) | 0.626 | 1.041(0.988, 1.097) | 0.135 |
Allocystathionine | 1.014(0.929, 1.106) | 0.756 | 1.068(0.992, 1.150) | 0.083 |
Threoninyl-Phenylalanine | 0.999(0.998, 1.001) | 0.558 | 1.000(0.999, 1.002) | 0.623 |
Adjusted for age, gender, BMI, FEV1 | Adjusted for age, gender, BMI, FEV1 | Adjusted for age, gender, BMI, FEV1 | Adjusted for age, gender, BMI, FEV1 | Adjusted for age, gender, BMI, FEV1 |